Revisions of 'Thalidomide embryopathy'
-
Revision 10 - created 9 months ago by Ryan Thibodeau - view changesetDate: 2023-10-06 05:38:13 UTC Disclosures:
At the time the revision was created Ryan Thibodeau had no financial relationships to ineligible companies to disclose.
View Ryan Thibodeau's current disclosures Reviewed by: Joachim Feger -
Revision 9 - created 10 months ago by Henry Knipe - view changesetDate: 2023-09-29 10:25:30 UTC Disclosures:
At the time the revision was created Henry Knipe had the following disclosures:
- Integral Diagnostics, Shareholder (ongoing)
- Micro-X Ltd, Shareholder (ongoing)
These were assessed during peer review and were determined to not be relevant to the changes that were made.
View Henry Knipe's current disclosures Reviewed by: Ryan Thibodeau -
Revision 8 - created 10 months ago by Mostafa Elfeky - view changesetDate: 2023-09-28 23:52:14 UTC Disclosures:
At the time the revision was created Mostafa Elfeky had no financial relationships to ineligible companies to disclose.
View Mostafa Elfeky's current disclosures Reviewed by: Joachim Feger -
Revision 7 - created 10 months ago by Dalia Ibrahim - view changesetDate: 2023-09-26 08:19:22 UTC Disclosures:
At the time the revision was created Dalia Ibrahim had no financial relationships to ineligible companies to disclose.
View Dalia Ibrahim's current disclosures Reviewed by: Henry Knipe -
Revision 6 - created 10 months ago by Arlene Campos - view changesetDate: 2023-09-25 23:24:03 UTC Disclosures:
At the time the revision was created Arlene Campos had no financial relationships to ineligible companies to disclose.
View Arlene Campos's current disclosures Reviewed by: Henry Knipe -
Revision 5 - created 10 months ago by Evangeline Collins - view changesetDate: 2023-09-25 14:18:19 UTC Disclosures:
At the time the revision was created Evangeline Collins had no financial relationships to ineligible companies to disclose.
View Evangeline Collins's current disclosures Reviewed by: Henry Knipe -
Revision 4 - created 10 months ago by Arlene Campos - view changesetDate: 2023-09-25 00:08:45 UTC Disclosures:
At the time the revision was created Arlene Campos had no financial relationships to ineligible companies to disclose.
View Arlene Campos's current disclosures Reviewed by: Henry Knipe -
Revision 3 - created 10 months ago by Evangeline Collins - view changesetDate: 2023-09-22 13:57:29 UTC Disclosures:
At the time the revision was created Evangeline Collins had no financial relationships to ineligible companies to disclose.
View Evangeline Collins's current disclosures Reviewed by: Arlene Campos -
Revision 2 - created 10 months ago by Evangeline Collins - view changesetDate: 2023-09-22 07:39:18 UTC Disclosures:
At the time the revision was created Evangeline Collins had no financial relationships to ineligible companies to disclose.
View Evangeline Collins's current disclosures Reviewed by: Jeremy Jones -
Revision 1 - created 10 months ago by Evangeline Collins - view changesetDate: 2023-09-21 11:57:53 UTC Disclosures:
At the time the revision was created Evangeline Collins had no financial relationships to ineligible companies to disclose.
View Evangeline Collins's current disclosures Reviewed by: Karen Machang'a
Unfortunately some older revisions may not be able to be viewed or restored.
Radiopaedia.org is a collaborative effort and anyone can contribute. Every revision counts. Learn more about contributing.
Each article also undergoes a sophisticated editorial process to ensure the high quality of Radiopaedia.org. Through open contributions by many different medical professionals, editorial oversight from our excellent editorial and expert review boards, and continual moderation, we can continue to provide the best, free radiology resource online.